PD Dr. Marlen Haderlein

Medizinische Fakultät Department of Radiation Oncology

High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases (2021) Freitag V, Lettmaier S, Semrau S, Hecht M, Mantsopoulos K, Müller-Hübner SKU, Traxdorf M, et al. Journal article Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article High locoregional Control Rates after Radio (chemo) Therapy in anaplastic Thyroid Carcinoma - a monocentric Analysis (2020) Schmied M, Semrau S, Hecht M, Lettmaier S, Mantsopoulos K, Traxdorf M, Iro H, et al. Conference contribution Effectiveness of ablative Irradiation of all Metastases versus Irradiation of a singular Metastasis in Combination with Immunocheckpoint Inhibitors - clinical Evaluation of prospective STICI Study (2020) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Prognostic Significance of immune-associated Side Effects under Radioimmunotherapy and Immunotherapy alone in Patients of the prospective ST-ICI Study (2020) Schweizer C, Schubert P, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, Becker I, et al. Conference contribution Use of NGS Gene Panel Analyzes for molecularly targeted System Therapy (2020) Roesch J, Haller F, Lettmaier S, Haderlein M, Hartmann A, Moskalev E, Tögel L, et al. Conference contribution Comparison of Intrinsic PAM50 Gene Expression Analysis and Immunohistochemical Subtypes of Salivary Duct Carcinoma (2020) Erber R, Stoehr R, Haller F, Haderlein M, Hartmann A, Agaimy A Conference contribution Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: First (treatment planning) results of the prospective multicenter DIREKHT trial (2020) Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, et al. Journal article Secondary Tracheoesophageal Puncture After Laryngectomy Increases Complications With Shunt and Voice Prosthesis (2020) Scherl C, Kauffels J, Schützenberger A, Döllinger M, Bohr C, Dürr S, Fietkau R, et al. Journal article